Athena Health Shareholders Blindsided with Restated Outlook
Athena Health (NASDAQ:ATHN) drops sharply after forecasting 2012 revenue guidance of $410M-$430M and EPS guidance of $0.85-$0.97. Although the revenue guidance corresponds with a consensus of $423.5M, the EPS guidance is far below a consensus of $1.16. At this time, Athena is hosting its annual Investor Summit.
Here’s how shares of Athena Health are tanking now:
Athenahealth, Inc. (NASDAQ:ATHN): ATHN shares recently traded at $48.43, down $9.6, or 16.54%. They have traded in a 52-week range of $38.08 to $72.70. Volume today was 9,683,222 shares versus a 3-month average volume of 685,375 shares. The company’s trailing P/E is 82.22, while trailing earnings are $0.59 per share. Get the most recent company news and stock data here >>